Cryo-Cell International (FRA:ZCY) Cyclically Adjusted FCF per Share: €0.44 (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZCY Cryo-Cell International Inc FRA:ZCY
66 GF Score
Price €2.84
GF Value €4.69
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International Cyclically Adjusted FCF per Share?

Cryo-Cell International FRA:ZCY -1.39% 66 Cyclically Adjusted FCF per Share is €0.44 as of May. 2026. GuruFocus rates FRA:ZCY with a GF Score™ of 66/100 and a GF Value™ of €4.69 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Cryo-Cell International's adjusted free cash flow per share for the three months ended in May. 2026 was €0.193. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.44 for the trailing ten years ended in May. 2026.

During the past 12 months, Cryo-Cell International's average Cyclically Adjusted FCF Growth Rate was 8.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 4.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 0.70% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Cryo-Cell International was 63.00% per year. The lowest was -1.40% per year. And the median was 26.00% per year.

As of today (2026-07-27), Cryo-Cell International's current stock price is €2.84. Cryo-Cell International's Cyclically Adjusted FCF per Share for the quarter that ended in May. 2026 was €0.44. Cryo-Cell International's Cyclically Adjusted Price-to-FCF of today is 6.45.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Cryo-Cell International was 44.56. The lowest was 5.69. And the median was 18.68.


Cryo-Cell International  (FRA:ZCY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Cryo-Cell International's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=2.84/0.44
=6.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Cryo-Cell International was 44.56. The lowest was 5.69. And the median was 18.68.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Cryo-Cell International Cyclically Adjusted FCF per Share Related Terms


Cryo-Cell International Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International Cyclically Adjusted FCF per Share Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.42 0.42 0.44 0.36

Cryo-Cell International Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.39 0.36 0.39 0.44

FRA:ZCY vs EHSI, PIII, CCM: Cyclically Adjusted FCF per Share Comparison

For the Medical Care Facilities subindustry, Cryo-Cell International's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International Cyclically Adjusted Price-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's Cyclically Adjusted Price-to-FCF falls into.


FRA:ZCY
66GF Score
Cryo-Cell International Inc FRA:ZCY
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cryo-Cell International's adjusted Free Cash Flow per Share data for the three months ended in May. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of May. 2026 (Change)*Current CPI (May. 2026)
=0.193/335.1230*335.1230
=0.193

Current CPI (May. 2026) = 335.1230.

Cryo-Cell International Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201608 0.126 240.849 0.175
201611 0.343 241.353 0.476
201702 0.054 243.603 0.074
201705 0.229 244.733 0.314
201708 0.128 245.519 0.175
201711 0.231 246.669 0.314
201802 0.141 248.991 0.190
201805 0.003 251.588 0.004
201808 0.270 252.146 0.359
201811 0.091 252.038 0.121
201902 0.189 252.776 0.251
201905 0.018 256.092 0.024
201908 0.286 256.558 0.374
201911 0.105 257.208 0.137
202002 0.294 258.678 0.381
202005 0.088 256.394 0.115
202008 0.176 259.918 0.227
202011 0.304 260.229 0.391
202102 0.252 263.014 0.321
202105 -0.341 269.195 -0.425
202108 0.052 273.567 0.064
202111 0.141 277.948 0.170
202202 -0.417 283.716 -0.493
202205 0.181 292.296 0.208
202208 -1.004 296.171 -1.136
202211 0.283 297.711 0.319
202302 0.140 300.840 0.156
202305 0.015 304.127 0.017
202308 -0.164 307.026 -0.179
202311 0.152 307.051 0.166
202402 -0.092 310.326 -0.099
202405 -0.103 314.069 -0.110
202408 0.235 314.796 0.250
202411 0.234 315.493 0.249
202502 0.104 319.082 0.109
202505 0.070 321.465 0.073
202508 0.266 323.976 0.275
202511 0.130 324.122 0.134
202602 0.061 326.785 0.063
202605 0.193 335.123 0.193

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.44 mean?
Cryo-Cell International (FRA:ZCY) has a Cyclically Adjusted FCF per Share of €0.44 as of May. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Cryo-Cell International and its competitors.
Is Cryo-Cell International's Cyclically Adjusted FCF per Share too high?
Cryo-Cell International's current Cyclically Adjusted FCF per Share is €0.44. Overall, Cryo-Cell International has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's Cyclically Adjusted FCF per Share compare to EHSI and PIII?
Cryo-Cell International's Cyclically Adjusted FCF per Share of €0.44 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted FCF per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Cryo-Cell International and its competitors. Cryo-Cell International's current Cyclically Adjusted FCF per Share is €0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Based on GuruFocus' analysis, Cryo-Cell International (FRA:ZCY) is currently considered Possible Value Trap. The stock's GF Value™ is €4.69, compared to a current price of €2.84 — trading 39.4% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.44. Cryo-Cell International's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Cryo-Cell International (FRA:ZCY), the current Cyclically Adjusted FCF per Share is €0.44 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryo-Cell International (FRA:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €2.84 is trading 39.4% below its estimated GF Value™ of €4.69. GuruFocus considers Cryo-Cell International to be Possible Value Trap.

Key valuation signals for FRA:ZCY:

  • Cyclically Adjusted FCF per Share: €0.44
  • GF Value™: €4.69 vs. price of €2.84 (39.4% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the FRA:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cryo-Cell International Business Description

Other Exchanges CCEL:USA
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
66GF Score

Get the complete analysis for FRA:ZCY

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.84
Price
€4.69
GF Value